Closing Bell: Knight Therapeutics Inc down on Friday (GUD)
Today in trading, shares of Knight Therapeutics Inc opened at $5.80 and closed at $5.55. Intraday prices ranged from a low of $5.50 to a high of $5.80.
The price slipped -2.12% from the previous day's close of $5.67.
During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.
Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).
A total of 64,994 shares was traded during the session, with total trades of 342. On average, Knight Therapeutics Inc has traded 52,858 shares over 5 days and 65,078 year-to-date.
Trading across the entire TSX saw 432 price advancers against 4,843 declines and 43 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have boosted 15.62 percent, while they have raised 6.94% this year.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $562.64 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
